BROWARD HEALTH NORTH — History
CCN 100086 | 3-year financial timeline | COVID resilience: 61/100
🛡️ Public data only — no PHI permitted on this instance.
$254M
Latest Revenue (FY2022)
+7.5%
Revenue CAGR (3yr)
-17.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $220M | $264M | $254M | -3.6% | +7.5% |
| Operating Expenses | $259M | $327M | $298M | -8.8% | +7.3% |
| Operating Margin | -17.6% | -24.0% | -17.2% | +28.1% | +0.0% |
| Net Income | $-39M | $-63M | $-44M | +30.7% | +0.0% |
| Licensed Beds | 304 | 304 | 304 | +0.0% | +0.0% |
| Total Patient Days | 65,469 | 68,534 | 58,667 | -14.4% | -5.3% |
| Medicare Day % | 22% | 20% | 21% | +2.6% | -2.2% |
| Medicaid Day % | 7% | 7% | 5% | -36.2% | -16.2% |
COVID Impact & Recovery
Resilience Score: 61/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.5% ($220M → $254M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-17.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $271M | -17.0% |
| FY2024 (proj) | $288M | -16.8% |
| FY2025 (proj) | $305M | -16.6% |